For research use only. Not for human consumption.
Sermorelin (GRF 1-29) is a synthetic 29-amino-acid peptide corresponding to the shortest fully functional amino-terminal fragment of naturally occurring Growth Hormone-Releasing Hormone (GHRH).
$75.00
Sermorelin (GRF 1-29) is a synthetic 29-amino-acid peptide corresponding to the shortest fully functional amino-terminal fragment of naturally occurring Growth Hormone-Releasing Hormone (GHRH). It binds directly to the GHRH receptor on the anterior pituitary gland to stimulate the secretion of endogenous Growth Hormone (GH) in a natural, pulsatile manner.
Pulsatile Growth Hormone Release: Studied for its ability to mimic natural hypothalamic signaling, inducing natural secretory peaks of GH while maintaining normal negative feedback loops via somatostatin.
IGF-1 Pathway Elevation: Evaluated for downstream stimulation of hepatic insulin-like growth factor 1 (IGF-1), supporting cellular repair, protein synthesis, and tissue maintenance.
Pituitary Reserve Testing & Aging Dynamics: Researched in endocrine models to evaluate pituitary secretagogue responsiveness, sleep architecture optimization, and body composition changes.
To provide a bioidentical GHRH fragment for investigating pituitary gland signaling, natural GH secretion dynamics, IGF-1 synthesis, and neuroendocrine axis function in laboratory research.
| Property | Details |
| Product Name | Sermorelin |
| Product Category | Growth Hormone Releasing Hormones (GHRH) |
| Compound Type | Synthetic 29-Amino-Acid Peptide Fragment (GRF 1-29) |
| Primary Goal | GHRH receptor activation, endogenous GH release, and endocrine axis research |
| Form | Lyophilized powder (vial) |
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. Protect from direct light. |
| Intended Use | Laboratory Research Only |
| Dosage | 10MG |
|---|
Explore similar research-grade peptides, selected to complement your research needs.
